Phase II Trial of SBRT and Hormone Therapy for Oligometastases in Prostate Cancer

被引：2

作者：

Conde-Moreno, A. J. ^{[1
]}

Lopez, F. ^{[2
]}

Hervas, A. ^{[2
]}

Piquer Camanes, T. ^{[3
]}

Mendez, A. ^{[4
]}

Puertas, M. D. M. ^{[5
]}

Valero, J. J. ^{[6
]}

Gomez Iturriaga, A. ^{[7
]}

Rico, M. ^{[8
]}

Vazquez de la Torre, M. L. ^{[9
]}

Samper Ots, P. M. ^{[10
]}

Perez Romasanta, L. A. ^{[11
]}

Pastor Peidro, J. ^{[12
]}

Ibanez, C. ^{[13
]}

Ferrer, F. ^{[14
]}

Porras-Martinez, M. ^{[15
]}

Zapatero, A. ^{[16
]}

Garcia Blanco, A. S. ^{[17
]}

Rodriguez, A. ^{[18
]}

Ferrer, C. ^{[19
]}

机构：

[1] Hosp Univ & Politecn La Fe, Valencia, Spain

[2] Hosp Univ Ramon y Cajal, Madrid, Spain

[3] Consorcio Hosp Prov Castellon, Castellon de La Plana, Spain

[4] Miguel Servet Univ Hosp, Zaragoza, Spain

[5] Hosp Miguel Servet, Zaragoza, Spain

[6] Univ Hosp HM Sanchinarro Puerta del Sur, Madrid, Spain

[7] Cruces Univ Hosp, Baracaldo, Spain

[8] Complejo Hosp Navarra, Pamplona, Spain

[9] Hosp Meixoeiro, Vigo, Spain

[10] Hosp Univ Rey Juan Carlos, Madrid, Spain

[11] Hosp Clin Salamanca, Salamanca, Spain

[12] Hosp Gen Valencia, Valencia, Spain

[13] Hosp Cent Def Gomez Ulla, Madrid, Spain

[14] Catalan Inst Oncol, Dept Radiat Oncol, Lhospitalet Barcelona, Spain

[15] Hosp Univ Virgen de la Arrixaca, Murcia, Spain

[16] Hosp Univ La Princesa, Madrid, Spain

[17] Hosp Univ Marques de Valdecilla, Santander, Spain

[18] Hosp Ruber, Madrid, Spain

[19] Hosp Prov Castellon, Castellon de La Plana, Spain

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2019年 / 105卷 / 01期

关键词：

D O I：

10.1016/j.ijrobp.2019.06.155

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1075

引用

页码：S149 / S150

页数：2

共 50 条

[31] SBRT of lung and liver oligometastases from breast cancer:a prospective non-randomized phase 2 trial
Marini, B.
Di Cristina, L.
Vernier, V.
Spoto, R.
Dominici, L.
Lobefalo, F.
Paganini, L.
Franzese, C.
Franceschini, D.
Scorsetti, M.
RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S812 - S813
[32] Urethra-sparing SBRT for prostate cancer: acute toxicity results from a randomized phase II trial
Zilli, T.
Jorcano, S.
Bral, S.
Rubio, C.
Bruynzeel, A.
Oliveira, A.
Abacioglu, U.
Minn, H.
Symon, Z.
Miralbell, R.
RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S295 - S295
[33] A phase II trial for the optimisation of treatment position in the radiation therapy of prostate cancer
O'Neill, Louise
Armstrong, John
Buckney, Steve
Assiri, Mushabbab
Cannon, Mairin
Holmberg, Ola
RADIOTHERAPY AND ONCOLOGY, 2008, 88 (01) : 61 - 66
[34] A Phase I/II Trial of Increasingly Hypofractionated Radiation Therapy for Prostate Cancer
Ritter, M. A.
Forman, J. D.
Kupelian, P. A.
Petereit, D. G.
Lawton, C. A.
Chappell, R. J.
Tome, W. A.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S80 - S81
[35] Early experience and quality of life in SBRT prostate cancer boost of 9 Gy in a phase II trial.
Ferrer, F.
Pont, A.
De Blas, R.
Boladeras, A.
Garin, O.
Ventura, M.
Zardoya, E.
Delgado, J.
Condom, E.
Merino, E.
Mases, J.
Castells, M.
Guix, I.
Suarez, J. F.
Gonzalez, J.
Almendros, S.
Garcia, M.
Berenguer, M. A.
Garcia, N.
Stefanovic, M.
Gutierrez, C.
Picon, C.
Ferrer, M.
Guedea, F.
RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S830 - S831
[36] Phase II study of oral vinorelbine plus hormone therapy in hormone-refractory prostate cancer
Chiti, F.
Calais da Silva, F. M.
Canelas, A.
Goncalves, P.
Gomes, J. M.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[37] Phase II study of intravenous vinorelbine plus hormone therapy in hormone-refractory prostate cancer
不详
EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 95 - 95
[38] A RANDOMIZED PHASE II TRIAL OF PROSTATE BOOST IRRADIATION WITH STEREOTACTIC BODY RADIOTHERAPY (SBRT) IN HIGH-RISK PROSTATE CANCER. THE PBS TRIAL
Douvi, Georgia
Isfahanian, Naghmeh
Lukka, Himanshu
IanDayes
Quan, Kimmen
Schnarr, Kara Lynne
Goldberg, Mira
Wright, Jim
Hallock, Abhirami
Ishkanian, Adrian
Cuthbert, David
Swaminath, Anand
Chow, Tom
Diamond, Kevin
Cutz, Jean-Claude
Kavsak, Peter
Thabane, Lehana
Tsakiridis, Theodoros
RADIOTHERAPY AND ONCOLOGY, 2020, 150 : S87 - S88
[39] Short-Term Outcomes and Clinical Efficacy of Stereotactic Body Radiation Therapy (SBRT) for Oligometastases of Prostate Cancer in China
Xu, Chenyang
Zhao, Xianzhi
Ju, Xiaoping
Shen, Yuxin
Qu, Min
Ye, Yusheng
Wang, Xiaoyan
Yu, Chunshan
Gao, Xu
Zhang, Huojun
FRONTIERS IN ONCOLOGY, 2022, 12
[40] Phase II trial of nab-paclitaxel as first-line therapy of hormone refractory metastatic prostate cancer (HRPC)
Kolevska, T.
Ryan, C. J.
Huey, V.
Weisberg, L.
Wang, S.
Baer, D.
Ghadialy, A.
Goldstein, D.
Fireman, B.
Fehrenbacher, L.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)

← 1 2 3 4 5 →